Prediction model for medication adherence using a medication event monitoring system in recurrent major depressive disorder

利用药物事件监测系统预测复发性重度抑郁症患者的药物依从性

阅读:2

Abstract

To investigate the risk factors associated with nonadherence to antidepressive drugs in patients with recurrent major depressive disorder (MDD). A total of 847 patients undergoing maintenance treatment for recurrent MDD were prospectively enrolled. One year after discharge, patients' adherence to the prescribed antidepressants was tracked over a 30-day period using the medication event monitoring system. Low adherence was identified in 30.7% of cases. Patients with more than three exacerbations had a 2.040-fold higher risk of low adherence ( P < 0.025). Those with drug concentrations below or above the recommended therapeutic range had a 2.096-fold ( P  < 0.025) and 2.361-fold ( P  < 0.05) increased risk of low adherence. Patients rating their depression severity from mild-to-severe showed a trend toward increased risk of low adherence, with odds ratios (ORs) of 2.020 (NS), 4.644 ( P  < 0.025), and 5.347 ( P  < 0.025). Patients reporting mild to severe side effects exhibited higher risks of low adherence, with ORs of 2.212 (NS), 3.993 ( P  < 0.05), and 10.965 ( P  < 0.001), respectively. Conversely, older age and Drug Attitude Inventory-10 scores greater than 0 were positive predictors of adherence. A prognostic index greater than or equal to 0.800 indicated a high risk of developing low adherence. A predictive model was established to assess adherence after 1 year of maintenance treatment for recurrent MDD. Patients at high risk of low adherence could be promptly identified and closely monitored, enabling physicians to develop targeted strategies to improve adherence.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。